A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis
- 1 November 1991
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 101 (5), 1382-1390
- https://doi.org/10.1016/0016-5085(91)90092-y
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Plasminogen activator inhibitorsBlood, 1987
- Haemostatic problems in liver disease.Gut, 1986
- Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassayThrombosis Research, 1984
- Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *JCI Insight, 1979
- Annotation.British Journal of Haematology, 1975
- The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastasesJournal of Clinical Pathology, 1971
- ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSISThe Lancet, 1964
- LIVER IN REGULATION OF FIBRINOLYTIC ACTIVITYThe Lancet, 1964
- Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*JCI Insight, 1964
- PLASMA FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVERThe Lancet, 1956